Bottom line
RYHCX vs SWHFX: the short answer
RYHCX (Health Care Fund) and SWHFX (Schwab Health Care Fund) are both mutual funds.
SWHFX is cheaper at 0.8% vs 2.4% — a difference of $160 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +4.1% for RYHCX.
Updated Nov 19, 2026
RYHCX vs SWHFX side by side
| RYHCX | SWHFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.4% | 0.8% |
| Annual cost per $10k | $240 | $80 |
| 10-yr cost on $10k (prospectus) | $2,782 | $990 |
| Max front load | 0% | — |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +12.3% | +15.9% |
| 5-yr return (annualized) | +4.1% | +6.5% |
| 10-yr return (annualized) | +6.8% | +8.1% |
| Best quarter | +18.4% | +15.3% |
| Worst quarter | −14.6% | −12.1% |
| Net assets (fund) | $19.4M | $642.3M |
| Number of holdings | 135 | 80 |
| Portfolio turnover | 244% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYHCX | SWHFX | Difference |
|---|---|---|---|
| 2025 | +13.3% | +15.9% | −2.6% |
| 2024 | −0.4% | +0.1% | −0.5% |
| 2023 | +4.8% | +0.7% | +4.2% |
| 2022 | −12.5% | −4.7% | −7.8% |
| 2021 | +18.1% | +23.3% | −5.2% |
| 2020 | +17.7% | +12.9% | +4.9% |
| 2019 | +21.6% | +17.6% | +4.0% |
| 2018 | +0.5% | +4.0% | −3.5% |
| 2017 | +22.3% | +20.2% | +2.1% |
| 2016 | −10.3% | −4.4% | −5.9% |
Source: Fund prospectus bar charts
Holdings overlap
16 of RYHCX's top 25 holdings also appear in SWHFX's top 25.
| Holding | RYHCX | SWHFX |
|---|---|---|
| Eli Lilly & Company | 3.63% | 13.92% |
| Johnson & Johnson | 2.88% | 6.94% |
| Abbvie Inc | 2.52% | 5.81% |
| Unitedhealth Group Inc | 2.22% | 4.74% |
| Merck & Company Inc | 2.04% | 4.98% |
| Thermo Fisher Scientific Inc | 1.61% | 2.16% |
| Amgen Inc | 1.56% | 2.58% |
| Abbott Laboratories | 1.42% | 1.60% |
| Gilead Sciences Inc | 1.39% | 3.24% |
| Vertex Pharmaceuticals Inc | 1.34% | 1.89% |
| Danaher Corp | 1.30% | 1.47% |
| Bristol-myers Squibb Company | 1.22% | 2.44% |
| Stryker Corp | 1.21% | 2.11% |
| Elevance Health Inc | 1.02% | 1.45% |
| Cigna Group (the) | 0.94% | 1.51% |
Source: SEC Form N-PORT
RYHCX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between RYHCX and SWHFX?
Which is cheaper, RYHCX or SWHFX?
Should I own both RYHCX and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.